Therapy Areas: Vaccines
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
11 August 2025 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that it has secured US Food and Drug Administration priority review for a supplemental New Drug Applicatio...
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
8 August 2025 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Friday that it will receive a USD370m upfront settlement following the resolution of mRNA patent litigation between ...
ViruSure and Oxford Nanopore launch first nanopore-based viral contamination test for biomanufacturing
7 August 2025 - ViruSure, a provider of pathogen safety testing for biopharmaceuticals, on Thursday announced the launch of the first Good Laboratory Practice (GLP)-validated adventitious viral agent ...
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
7 August 2025 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Thursday that the US Food and Drug Administration has lifted its recommended pause on the use of IXCHIQ in in...
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial
5 August 2025 - Anixa Biosciences Inc (NASDAQ:ANIX), a California-based biotechnology company focused on the treatment and prevention of cancer, announced on Monday that, in collaboration with Clevela...
Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine
25 July 2025 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and German biotechnology company BioNTech SE ADR (NASDAQ:BNTX) have received a positive opinion from the European Medicines Agency...